CPMD Gross Margin

The Gross Margin of CannaPharmaRx Inc (CPMD) is -128.03%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CPMD Gross Margin - Historical Value

Date	Value
2024-12-31	-128.03%

CPMD Gross Margin - Peers Comparison

Ticker	Name	Value
NSHS.CN	NanoSphere Health Sciences Inc	7775.20%
NXEN	Nexien Biopharma Inc	16.58%
SPR.CN	Sproutly Canada Inc	-107.40%
SUGR.V	Sucro Ltd	13.02%
IPCI.TO	Intellipharmaceutics International Inc	100.00%
BSEM	Biostem Technologies Inc	95.45%
CBDX	Curative Biosciences Inc	34.75%
EXM.CN	Exmceuticals Inc	7775.20%
KAYS	Kaya Holdings Inc	-5.19%
NOUV	Nouveau Life Pharmaceuticals Inc	7775.20%
PLSI	Phoenix Life Sciences International Ltd	27.05%
RSPI	RespireRx Pharmaceuticals Inc	7775.20%
AQS.V	Aequus Pharmaceuticals Inc	56.88%
SNES	Senestech Inc	54.07%
CHM.CN	Chemistree Technology Inc	25.49%
CVGR.CN	City View Green Holdings Inc	23.22%
ERBB	American Green Inc	7775.20%
GNOM.CN	Gnomestar Craft Inc	-56.86%
MJ.CN	Maven Brands Inc	45.81%
MLCL.CN	Molecule Holdings Inc	-54.56%
AVCR.V	Avricore Health Inc	39.29%
POT.CN	Potent Ventures Inc	5.98%
KOAN	APOLLO BioWellness Inc	65.19%
NGBL	Notis Global Inc	-5.61%
BSPK	Bespoke Extracts Inc	40.53%